Novavax, Inc. (NVAX)
10.18
-0.04
(-0.34%)
USD |
NASDAQ |
Sep 08, 15:59
10.15
-0.04
(-0.34%)
After-Hours: 19:51
Novavax Market Cap : 1.679B for Sept. 8, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 04, 2026 | 1.684B |
| September 03, 2026 | 1.704B |
| September 02, 2026 | 1.701B |
| September 01, 2026 | 1.668B |
| August 31, 2026 | 1.544B |
| August 28, 2026 | 1.526B |
| August 27, 2026 | 1.492B |
| August 26, 2026 | 1.518B |
| August 25, 2026 | 1.556B |
| August 24, 2026 | 1.460B |
| August 21, 2026 | 1.473B |
| August 20, 2026 | 1.388B |
| August 19, 2026 | 1.449B |
| August 18, 2026 | 1.307B |
| August 17, 2026 | 1.330B |
| August 14, 2026 | 1.327B |
| August 13, 2026 | 1.342B |
| August 12, 2026 | 1.312B |
| August 11, 2026 | 1.310B |
| August 10, 2026 | 1.300B |
| August 07, 2026 | 1.310B |
| August 06, 2026 | 1.276B |
| August 05, 2026 | 1.269B |
| August 04, 2026 | 1.262B |
| August 03, 2026 | 1.218B |
| Date | Value |
|---|---|
| July 31, 2026 | 1.204B |
| July 30, 2026 | 1.223B |
| July 29, 2026 | 1.207B |
| July 28, 2026 | 1.212B |
| July 27, 2026 | 1.232B |
| July 24, 2026 | 1.227B |
| July 23, 2026 | 1.287B |
| July 22, 2026 | 1.301B |
| July 21, 2026 | 1.328B |
| July 20, 2026 | 1.296B |
| July 17, 2026 | 1.350B |
| July 16, 2026 | 1.355B |
| July 15, 2026 | 1.386B |
| July 14, 2026 | 1.384B |
| July 13, 2026 | 1.465B |
| July 10, 2026 | 1.534B |
| July 09, 2026 | 1.546B |
| July 08, 2026 | 1.537B |
| July 07, 2026 | 1.555B |
| July 06, 2026 | 1.537B |
| July 02, 2026 | 1.601B |
| July 01, 2026 | 1.555B |
| June 30, 2026 | 1.549B |
| June 29, 2026 | 1.539B |
| June 26, 2026 | 1.460B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Moderna, Inc. | 55.96B |
| Merck & Co., Inc. | 366.54B |
| Pfizer Inc. | 158.38B |
| Recursion Pharmaceuticals, Inc. | 1.835B |
| Agenus, Inc. | 316.85M |
Market Cap Related Metrics
| PS Ratio | 4.033 |
| Price | 10.18 |
| Earnings Yield | -14.95% |